Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major Health Partners (MHP) has purchased and installed Gamma Medica’s LumaGEM molecular breast imaging (MBI) system. It is the state’s first LumaGEM and the hospital’s first MBI.

Siemens Healthineers has announced the expansion of its online learning platform PEPconnect (Personalized Education Plan) to include approximately 1,000 new learning modules for medical imaging customers. Effective immediately, physicians and medical technology assistants can use PEPconnect to access training courses on Siemens Healthineers systems for imaging and minimally invasive therapy in seven different languages: English, German, French, Italian, Spanish, Korean and Japanese.

Accuray Inc. announced recently that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new Radixact Treatment Delivery System, fully integrated with the new Accuray Precision Treatment Planning System and iDMS Data Management System.

Health Connect Partners 2017 Fall Radiology & Imaging Conference

Health Connect Partners 2017 Spring Radiology & Imaging Conference

In work published this week in the Journal of Clinical Investigation (JCI), a team led by Jacob Hooker at Harvard Medical School assessed GV1-57, a radiotracer that specifically binds to mature olfactory sensory neurons, as an approach for quantifying neuronal populations with positron emission tomography (PET) imaging.

Elekta announced new data demonstrating Leksell Gamma Knife better spares healthy brain tissue and delivers a higher radiation dose compared to linear accelerator (linac)-based delivery methods. The results, evaluating patients undergoing radiosurgery for large or complex brain tumors, were published in the Journal of Neurosurgery.

The ultrasound systems space, which covers 39 major markets, is set to rise steadily from $4.2 billion in 2016 to $5 billion by 2023, according to research and consulting firm GlobalData. This represents a compound annual growth rate (CAGR) of 2.5 percent. The company’s latest report states that the growth will primarily be driven by the rising prevalence of diseases and expanding demand for cost-effective quality healthcare.

HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now